General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lee WM et al. – Intravenous NAC improves transplant–free survival in patients with early stage non–acetaminophen–related acute liver failure. Patients with advanced coma grades do not benefit from NAC and typically require emergency liver transplantation.

Related Articles

Moderate hypothermia with intracranial pressure monitoring as a therapeutic paradigm for the management of acute liver failure: a systematic review
Intensive Care Medicine, 10/28/09    Relevance Score: 82%

Atypical Acute Leukemia Early After Liver Transplantation
Transplantation Proceedings, 11/17/09    Relevance Score: 81%

Racial and Ethnic Differences in Presentation, Etiology, and Outcomes of Acute Liver Failure in the United States
Clinical Gastroenterology and Hepatology, 10/09/09    Relevance Score: 81%

Results of Treatment of Acute Liver Failure Patients With Use of the Prometheus FPSA System
Transplantation Proceedings, 11/06/09    Relevance Score: 80%

Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient
World Journal of Gastroenterology, 10/06/09    Relevance Score: 79%

Today in Hepatology...keeping you current

Major hepatectomy for perihilar cholangiocarcinoma
Journal of Hepato-Biliary-Pancreatic Surgery, 12/01/09

Real-time MR thermometry for monitoring HIFU ablations of the liver
Magnetic Resonance in Medicine, 12/01/09

Fusion Technique for Liver Transection with Kelly-Clysis and Harmonic Technology
World Journal of Surgery, 12/01/09

Today in Pharmacology/kinetics...keeping you current

An evidence-based review of natalizumab therapy in the management of Crohn’s disease
Therapeutics and Clinical Risk Management, 12/01/09

Continuation of Low-Dose Aspirin in Peptic Ulcer Bleeding. A Randomized Trial
Annals of Internal Medicine, 12/01/09

Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer
Cancer Chemotherapy and Pharmacology, 12/01/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address